Ex Vivo Mesenchymal Stem Cell Therapy to Regenerate Machine Perfused Organs

Area of Science:

• Regenerative Medicine
• Transplant Immunology
• Biomedical Engineering

Background:

• Organ transplantation is limited by donor organ scarcity.
• Marginal quality organs from donors after cardiac death (DCD) and extended criteria donors (ECD) present an opportunity to expand the donor pool.
• Ex situ normothermic machine perfusion (NMP) offers a method for organ assessment and potential treatment before transplantation.

Purpose of the Study:

• To explore the potential of mesenchymal stem cells (MSCs) in enhancing organ quality during ex situ normothermic machine perfusion (NMP).
• To assess the feasibility and safety of using MSCs within the NMP system for organ preservation and potential regeneration.
• To highlight the need for further research to demonstrate clinical benefits of MSCs in NMP for transplantation.

Main Methods:

• Review of existing literature on MSCs and ex situ machine perfusion.
• Analysis of studies focusing on the application of MSCs during NMP.
• Identification of research gaps concerning MSCs in organ perfusion.

Main Results:

• Limited studies have investigated MSCs during ex situ NMP, primarily focusing on feasibility and safety.
• The anti-inflammatory, immunomodulatory, and regenerative properties of MSCs make them theoretically suitable for NMP applications.
• No conclusive clinical benefits of MSCs in NMP have been demonstrated to date.

Conclusions:

• MSCs hold potential as a therapeutic tool within NMP systems to improve organ quality for transplantation.
• Current evidence is limited, with a need for rigorous studies to validate the efficacy of MSCs in NMP.
• Controlled transplantation studies are essential to elucidate the benefits of MSCs for organs undergoing ex situ perfusion.